LncRNA LHFPL3-AS1 Promotes Oral Squamous Cell Carcinoma Growth and Cisplatin Resistance Through Targeting miR-362-5p/CHSY1 Pathway

被引:15
|
作者
Li, Jiandong [1 ]
Xu, Xiaohu [1 ]
Zhang, Dandan [1 ]
Lv, Han [1 ]
Lei, Xin [1 ]
机构
[1] Shenzhen Longhua Dist Cent Hosp, Dept Stomatol, Shenzhen 518000, Peoples R China
来源
ONCOTARGETS AND THERAPY | 2021年 / 14卷
关键词
oral squamous cell carcinoma; LHFPL3-AS1; miR-362-5p; CHSY1; CANCER METASTASIS; PROLIFERATION; INVASION; AXIS;
D O I
10.2147/OTT.S298679
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: Oral squamous cell carcinoma (OSCC) is a common oral cancer. The current study aims to elucidate the potential roles of long noncoding RNA (lncRNA) LHFPL3-AS1 in OSCC development. Methods: Gene expression was measured by qRT-PCR in tumor tissues and cell lines. Loss-of-function assays were performed to analyze the effects of LHFPL3-AS1 on malignant behaviors. Bioinformatics analysis was conducted to explore the downstream signaling pathway of LHFPL3-AS1 in OSCC. Results: LHFPL3-AS1 was highly expressed in OSCC tissues and cell lines. LHFPL3-AS1 was upregulated in cisplatin-resistant tumor cell lines. LHFPL3-AS1 level was correlated with survival rate. LHFPL3-AS1 knockdown suppressed OSCC proliferation, migration and invasion. LHFPL3-AS1 downregulation reduced cisplatin resistance of OSCC cells. LHFPL3-AS1 was the competing endogenous RNA (ceRNA) for miR-194-5p to enhance CHSY1 expression. Conclusion: LHFPL3-AS1/miR-362-5p/CHSY1 signaling pathway plays essential roles in regulating OSCC development and cisplatin resistance.
引用
收藏
页码:2293 / 2300
页数:8
相关论文
共 50 条
  • [11] LncRNA TTN-AS1 promotes the progression of oral squamous cell carcinoma via miR-411-3p/NFAT5 axis
    Fu, Su-Wei
    Zhang, Yan
    Li, Shen
    Shi, Zhi-Yan
    Zhao, Juan
    He, Qing-Li
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [12] MiR-769-5p inhibits cancer progression in oral squamous cell carcinoma by directly targeting JAK1/STAT3 pathway
    Zhou, Y.
    Xu, X. M.
    Feng, Y.
    NEOPLASMA, 2020, 67 (03) : 528 - +
  • [13] HOXA11-AS promotes the progression of oral squamous cell carcinoma by targeting the miR-518a-3p/PDK1 axis
    Li, Baojun
    Wang, Wei
    Miao, Susheng
    Li, Guofu
    Lv, Yuanjing
    Xiang, Cheng
    Pei, Rong
    CANCER CELL INTERNATIONAL, 2019, 19 (1)
  • [14] LncRNA PVT1 promotes malignant progression by regulating the miR-7-5p/CDKL1 axis in oral squamous cell carcinoma
    Li, Jun
    Ding, Shuxin
    Li, Min
    Zou, Bo
    Chu, Miaomiao
    Gu, Guohao
    Chen, Cheng
    Liu, Yu-jiao
    Zheng, Ke
    Meng, Zhen
    MOLECULAR AND CELLULAR PROBES, 2024, 78
  • [15] Involvement of miR-619-5p in resistance to cisplatin by regulating ATXN3 in oral squamous cell carcinoma
    Song, An
    Wu, Yuanyuan
    Chu, Weiming
    Yang, Xueming
    Zhu, Zaiou
    Yan, Enshi
    Zhang, Wei
    Zhou, Junbo
    Ding, Xu
    Liu, Jie
    Zhu, Hongxia
    Ye, Jinhai
    Wu, Yunong
    Zheng, Yang
    Song, Xiaomeng
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2021, 17 (02): : 430 - 447
  • [16] LncRNA BLACAT1 regulates the viability, migration and invasion of oral squamous cell carcinoma cells by targeting miR-142-5p
    Dai, D.
    Feng, X-D
    Zhu, W-Q
    Bao, Y-N
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (23) : 10313 - 10323
  • [17] MiR-149-5p regulates cisplatin chemosensitivity, cell growth, and metastasis of oral squamous cell carcinoma cells by targeting TGFβ2
    Luo, Kunliang
    He, Jun
    Yu, Dongqin
    Acil, Yahya
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2019, 12 (10): : 3728 - 3739
  • [18] Antisense lncRNA PCNA-AS1 promotes esophageal squamous cell carcinoma progression through the miR-2467-3p/PCNA axis
    Hu, Tao
    Niu, Yunfeng
    Fu, Jianfeng
    Dong, Zhiming
    He, Dongwei
    Liu, Junfeng
    OPEN MEDICINE, 2022, 17 (01): : 1483 - 1494
  • [19] hsa-miR-485-5p reverses epithelial to mesenchymal transition and promotes cisplatin-induced cell death by targeting PAK1 in oral tongue squamous cell carcinoma
    Lin, Xiu-Juan
    He, Chang-Li
    Sun, Ting
    Duan, Xue-Jing
    Sun, Yi
    Xiong, Shi-Jiang
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2017, 40 (01) : 83 - 89
  • [20] LncRNA TTN-AS1 promotes the progression of oral squamous cell carcinoma via miR-411-3p/NFAT5 axis
    Su-Wei Fu
    Yan Zhang
    Shen Li
    Zhi-Yan Shi
    Juan Zhao
    Qing-Li He
    Cancer Cell International, 20